LONDON BROKER RATINGS: Bernstein reinitiates Convatec at 'outperform'
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More
| Price | 68.10p on 20-02-2026 at 19:40:06 |
|---|---|
| Change | 0.85p 1.26% |
| Buy | 68.00p |
| Sell | 67.70p |
| Last Trade: | Buy 5,551.00 at 67.835p |
| Day's Volume: | 1,378,606 |
| Last Close: | 68.10p |
| Open: | 69.50p |
| ISIN: | GB00BL6NGV24 |
| Day's Range | 66.90p - 69.50p |
| 52wk Range: | 43.94p - 100.80p |
| Market Capitalisation: | £658.24m |
| VWAP: | 68.49662p |
| Shares in Issue: | 966.58m |
Dr. Martens (DOCS) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 5,551 | 67.835p | SI Trade Negotiated Trade |
16:47:10 - 20-Feb-26 |
| Buy* | 680,000 | 68.99684p | Suspected BUY Trade |
16:35:53 - 20-Feb-26 |
| Sell* | 100,000 | 68.10p | Ordinary |
16:35:53 - 20-Feb-26 |
| Sell* | 2,807 | 68.10p | SI Trade |
16:35:25 - 20-Feb-26 |
| Buy* | 213,935 | 68.10p | Suspected BUY Trade |
16:35:25 - 20-Feb-26 |
| Buy* | 1,092 | 67.75p | Automatic Execution |
16:29:27 - 20-Feb-26 |
| Buy* | 3,248 | 67.75p | Automatic Execution |
16:29:27 - 20-Feb-26 |
| Buy* | 438 | 67.70p | Automatic Execution |
16:29:27 - 20-Feb-26 |
| Buy* | 531 | 67.70p | Automatic Execution |
16:29:27 - 20-Feb-26 |
| Sell* | 350 | 67.65p | Automatic Execution |
16:29:27 - 20-Feb-26 |
Dr. Martens (DOCS) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 13th Feb 2026 10:49 am | RNS | Director/PDMR Shareholding |
| 30th Jan 2026 11:15 am | RNS | Total Voting Rights |
| 29th Jan 2026 7:00 am | RNS | EBT Share Purchase |
| 27th Jan 2026 7:00 am | RNS | Holding(s) in Company |
| 27th Jan 2026 7:00 am | RNS | Q3 FY26 Trading Statement |
| 15th Jan 2026 9:24 am | RNS | Director/PDMR Shareholding |
| 31st Dec 2025 11:11 am | RNS | Total Voting Rights |
| 31st Dec 2025 11:11 am | RNS | Total Voting Rights |
| 12th Dec 2025 3:00 pm | RNS | Director/PDMR Shareholding |
| 12th Dec 2025 7:00 am | RNS | Director/PDMR Shareholding |